Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results

Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Friday, Dow down 0.70% to 41,566.04, NASDAQ down 1.12% to 18,713.37, and S&P 500 down 0.87% to 5,791.25 [1] - Real estate shares fell by 0.1%, while information technology stocks dipped by 1.4% [1] Company Performance - Workday, Inc. (WDAY) shares dipped more than 11% after reporting quarterly earnings of $2.23 per share, beating the analyst consensus estimate of $2.01 by 10.95%. Quarterly revenue was $2.24 billion, exceeding the Street estimate of $2.22 billion. However, Workday projected second-quarter revenue of $2.16 billion, below the $2.34 billion analyst estimate [2] Commodity Market - Oil traded up 0.4% to $61.42, gold up 1.5% at $3,344.90, silver up 0.1% to $33.250, and copper rose 1% to $4.7245 [4] European Market - European shares were lower, with the eurozone's STOXX 600 falling 1.1%, Spain's IBEX 35 Index down 1.5%, London's FTSE 100 down 0.85%, Germany's DAX 40 declining 1.6%, and France's CAC 40 falling 1.9% [5] Asian Market - Asian markets closed mostly higher, with Japan's Nikkei gaining 0.47%, Hong Kong's Hang Seng Index rising 0.24%, China's Shanghai Composite Index falling 0.94%, and India's BSE Sensex gaining 0.95% [6] Stock Movements - Imunon, Inc. (IMNN) shares surged 155% to $1.07 after announcing new data from its Phase 2 OVATION 2 Study of IMNN-001. Powell Max Limited (PMAX) shares rose 84% to $0.5956, and BloomZ Inc. (BLMZ) shares gained 52% to $0.2033 following a business alliance announcement [8] - Conversely, Golden Heaven Group Holdings Ltd. (GDHG) shares dropped 51% to $2.26, and Bicara Therapeutics Inc. (BCAX) shares fell 42% to $9.06 after mixed results from a phase 1/1b trial [8] Housing Market - U.S. sales of new single-family homes climbed by 10.9% from the previous month to an annualized rate of 743,000 units [9]